Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 36, Issue 9, pp 1891–1900 | Cite as

Identification and characterization of RSIY-11, a novel seminal peptide derived from semenogelin-1, which acts as a neutral endopeptidase inhibitor modulating sperm motility

  • Rani Fritz
  • Amarnath Mukherjee
  • Sahar Zaghi
  • Ilir Agalliu
  • Sangita Jindal
  • Alexandre K. Tashima
  • Lloyd D. Fricker
  • Kelvin P. DaviesEmail author
Gamete Biology
  • 49 Downloads

Abstract

Purpose

Based on prior reports demonstrating that neutral endopeptidase (NEP) inhibitors increase sperm motility, the goal of our studies was to identify endogenous seminal peptides that inhibit NEP and investigate their potential effect on sperm motility.

Methods

Peptidomic analysis was performed on human seminal fluid, identifying 22 novel peptides. One peptide, named RSIY-11, derived from semenogelin-1, was predicted through sequence analysis to be a substrate and/or potential inhibitor of NEP. Enzymatic analysis was conducted to determine the inhibitory constant (Ki) of RSIY-11 as an inhibitor of NEP. Total and progressive sperm motility was determined at baseline and 30 and 60 min following addition of RSIY-11 to seminal fluid in 59 patients undergoing an infertility workup at an urban medical center. Additionally, the effects of RSIY-11 on sperm motility were evaluated in 15 of the 59 patients that met criteria for asthenospermia.

Results

RSIY-11 was shown to act as a competitive inhibitor of NEP with a Ki of 18.4 ± 1.6 μM. Addition of RSIY-11 at concentrations of 0.75 μM, 7.5 μM, and 75 μM significantly increased sperm motility at all time points investigated, with increases of 6.1%, 6.9%, and 9.2% at 60 min, respectively. Additionally, within the subgroup of patients with asthenospermia, RSIY-11 at concentrations of 0.75 μM, 7.5 μM, and 75 μM significantly increased sperm motility at all time points investigated, with increases of 7.6%, 8.8%, and 10.6% at 60 min, respectively.

Conclusions

RSIY-11 is a newly identified semenogelin-1-derived peptide present in seminal fluid. RSIY-11 acts as a potent competitive inhibitor of NEP, which when added to seminal fluid significantly increases sperm motility. RSIY-11 could play a potential role in the treatment for male factor infertility related to asthenospermia and improve intrauterine insemination outcomes.

Keywords

Semenogelin Asthenospermia Sperm motility Neutral endopeptidase inhibitor RSIY-11 

Notes

Funding information

Funding for these studies were provided by NIH R01 DK107807 (PI: Kelvin P. Davies) and by FINEP and FAPESP 2017/20106-9 (to A. K. Tashima).

Compliance with ethical standards

All studies involving human subjects were approved by the Institutional Review Board of Albert Einstein College of Medicine.

Supplementary material

10815_2019_1524_MOESM1_ESM.docx (178 kb)
ESM 1 (DOCX 177 kb)

References

  1. 1.
    Centers for Disease Control and Prevention. vol. 2017, 2016.Google Scholar
  2. 2.
    Larsen L, Scheike T, Jensen TK, Bonde JP, Ernst E, Hjollund NH, et al. Computer-assisted semen analysis parameters as predictors for fertility of men from the general population. The Danish First Pregnancy Planner Study Team. Hum Reprod. 2000;15:1562–7.CrossRefGoogle Scholar
  3. 3.
    Jouannet P, Ducot B, Feneux D, Spira A. Male factors and the likelihood of pregnancy in infertile couples. I. Study of sperm characteristics. Int J Androl. 1988;11:379–94.CrossRefGoogle Scholar
  4. 4.
    Zinaman MJ, Brown CC, Selevan SG, Clegg ED. Semen quality and human fertility: a prospective study with healthy couples. J Androl. 2000;21:145–53.Google Scholar
  5. 5.
    de Lamirande E. Semenogelin, the main protein of the human semen coagulum, regulates sperm function. Semin Thromb Hemost. 2007;33:60–8.CrossRefGoogle Scholar
  6. 6.
    Turner RM. Moving to the beat: a review of mammalian sperm motility regulation. Reprod Fertil Dev. 2006;18:25–38.CrossRefGoogle Scholar
  7. 7.
    Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231–45.CrossRefGoogle Scholar
  8. 8.
    Pilch B, Mann M. Large-scale and high-confidence proteomic analysis of human seminal plasma. Genome Biol. 2006;7:R40.CrossRefGoogle Scholar
  9. 9.
    Fung KY, Glode LM, Green S, Duncan MW. A comprehensive characterization of the peptide and protein constituents of human seminal fluid. Prostate. 2004;61:171–81.CrossRefGoogle Scholar
  10. 10.
    Pinto FM, Ravina CG, Subiran N, Cejudo-Roman A, Fernandez-Sanchez M, Irazusta J, et al. Autocrine regulation of human sperm motility by tachykinins. Reprod Biol Endocrinol. 2010;8:104.CrossRefGoogle Scholar
  11. 11.
    Subiran N, Agirregoitia E, Valdivia A, Ochoa C, Casis L, Irazusta J. Expression of enkephalin-degrading enzymes in human semen and implications for sperm motility. Fertil Steril. 2008;89:1571–7.CrossRefGoogle Scholar
  12. 12.
    Subiran N, Pinto FM, Agirregoitia E, Candenas L, Irazusta J. Control of APN/CD13 and NEP/CD10 on sperm motility. Asian J Androl. 2010;12:899–902.CrossRefGoogle Scholar
  13. 13.
    Iwamoto T, Gagnon C. Purification and characterization of a sperm motility inhibitor in human seminal plasma. J Androl. 1988;9:377–83.CrossRefGoogle Scholar
  14. 14.
    Iwamoto T, Gagnon C. A human seminal plasma protein blocks the motility of human spermatozoa. J Urol. 1988;140:1045–8.CrossRefGoogle Scholar
  15. 15.
    Robert M, Gibbs BF, Jacobson E, Gagnon C. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I. Biochemistry. 1997;36:3811–9.CrossRefGoogle Scholar
  16. 16.
    Lilja H, Abrahamsson PA, Lundwall A. Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. J Biol Chem. 1989;264:1894–900.Google Scholar
  17. 17.
    Rougeot C, Messaoudi M, Hermitte V, Rigault AG, Blisnick T, Dugave C, et al. Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity. Proc Natl Acad Sci U S A. 2003;100:8549–54.CrossRefGoogle Scholar
  18. 18.
    Bosler JS, Davies KP, Neal-Perry GS. Peptides in seminal fluid and their role in infertility: a potential role for opiorphin inhibition of neutral endopeptidase activity as a clinically relevant modulator of sperm motility: a review. Reprod Sci. 2014;21:1334–40.CrossRefGoogle Scholar
  19. 19.
    Wisner A, Dufour E, Messaoudi M, Nejdi A, Marcel A, Ungeheuer MN, et al. Human opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proc Natl Acad Sci U S A. 2006;103:17979–84.CrossRefGoogle Scholar
  20. 20.
    Fricker L. Quantitative peptidomics: general considerations. Methods Mol Biol. 1719;2018:121–40.Google Scholar
  21. 21.
    Fricker LD, Lim J, Pan H, Che FY. Peptidomics: identification and quantification of endogenous peptides in neuroendocrine tissues. Mass Spectrom Rev. 2006;25:327–44.CrossRefGoogle Scholar
  22. 22.
    Morano C, Zhang X, Fricker LD. Multiple isotopic labels for quantitative mass spectrometry. AnalChem. 2008;80:9298–309.Google Scholar
  23. 23.
    Wardman J, Fricker LD. Quantitative peptidomics of mice lacking peptide-processing enzymes. Methods Mol Biol. 2011;768:307–23.CrossRefGoogle Scholar
  24. 24.
    Rawlings ND, Barrett AJ, Thomas PD, Huang X, Bateman A, Finn RD. The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database. Nucleic Acids Res. 2018;46:D624–D32.CrossRefGoogle Scholar
  25. 25.
    Fricker LD. Limitations of mass spectrometry-based peptidomic approaches. J Am Soc Mass Spectrom. 2015;26:1981–91.CrossRefGoogle Scholar
  26. 26.
    Ulvsback M, Lazure C, Lilja H, Spurr NK, Rao VV, Loffler C, et al. Gene structure of semenogelin I and II. The predominant proteins in human semen are encoded by two homologous genes on chromosome 20. J Biol Chem. 1992;267:18080–4.Google Scholar
  27. 27.
    Fujisawa M, Kanzaki M, Okada H, Arakawa S, Kamidono S. Metenkephalin in seminal plasma of infertile men. Int J Urol. 1996;3:297–300.CrossRefGoogle Scholar
  28. 28.
    Siems WE, Maul B, Wiesner B, Becker M, Walther T, Rothe L, et al. Effects of kinins on mammalian spermatozoa and the impact of peptidolytic enzymes. Andrologia. 2003;35:44–54.CrossRefGoogle Scholar
  29. 29.
    Fernandez D, Valdivia A, Irazusta J, Ochoa C, Casis L. Peptidase activities in human semen. Peptides. 2002;23:461–8.CrossRefGoogle Scholar
  30. 30.
    Barazani Y, Agarwal A, Sabanegh ES Jr. Functional sperm testing and the role of proteomics in the evaluation of male infertility. Urology. 2014;84:255–61.CrossRefGoogle Scholar
  31. 31.
    Legare C, Droit A, Fournier F, Bourassa S, Force A, Cloutier F, et al. Investigation of male infertility using quantitative comparative proteomics. J Proteome Res. 2014;13:5403–14.CrossRefGoogle Scholar
  32. 32.
    Gilany K, Minai-Tehrani A, Amini M, Agharezaee N, Arjmand B. The challenge of human spermatozoa proteome: a systematic review. J Reprod Infertil. 2017;18:267–79.Google Scholar
  33. 33.
    Jodar M, Soler-Ventura A, Oliva R, Molecular Biology of R, Development Research G. Semen proteomics and male infertility. J Proteome. 2017;162:125–34.CrossRefGoogle Scholar
  34. 34.
    Samanta L, Parida R, Dias TR, Agarwal A. The enigmatic seminal plasma: a proteomics insight from ejaculation to fertilization. Reprod Biol Endocrinol. 2018;16:41.CrossRefGoogle Scholar
  35. 35.
    Pinto M, Rougeot C, Gracia L, Rosa M, Garcia A, Arsequell G, et al. Proposed bioactive conformations of opiorphin, an endogenous dual APN/NEP inhibitor. ACS Med Chem Lett. 2012;3:20–4.CrossRefGoogle Scholar
  36. 36.
    Irazusta J, Valdivia A, Fernandez D, Agirregoitia E, Ochoa C, Casis L. Enkephalin-degrading enzymes in normal and subfertile human semen. J Androl. 2004;25:733–9.CrossRefGoogle Scholar
  37. 37.
    Carlsson L, Ronquist G, Stridsberg M, Johansson L. Motility stimulant effects of prostasome inclusion in swim-up medium on cryopreserved human spermatozoa. Arch Androl. 1997;38:215–21.CrossRefGoogle Scholar
  38. 38.
    Ronquist G, Brody I. The prostasome: its secretion and function in man. Biochim Biophys Acta. 1985;822:203–18.CrossRefGoogle Scholar
  39. 39.
    Erdos EG, Skidgel RA. Human neutral endopeptidase 24.11 (NEP, enkephalinase); function, distribution and release. Adv Exp Med Biol. 1988;240:13–21.CrossRefGoogle Scholar
  40. 40.
    Erdos EG, Skidgel RA. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J. 1989;3:145–51.CrossRefGoogle Scholar
  41. 41.
    Connelly JC, Skidgel RA, Schulz WW, Johnson AR, Erdos EG. Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc Natl Acad Sci U S A. 1985;82:8737–41.CrossRefGoogle Scholar
  42. 42.
    Pierart ME, Najdovski T, Appelboom TE, Deschodt-Lanckman MM. Effect of human endopeptidase 24.11 (“enkephalinase”) on IL-1-induced thymocyte proliferation activity. J Immunol. 1988;140:3808–11.Google Scholar
  43. 43.
    Akiyama H, Kondo H, Ikeda K, Kato M, McGeer PL. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition. Brain Res. 2001;902:277–81.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Obstetrics, Gynecology & Women’s HealthAlbert Einstein College of Medicine/Montefiore Medical CenterNew YorkUSA
  2. 2.Montefiore’s Institute for Reproductive Medicine and HealthNew YorkUSA
  3. 3.Department of UrologyAlbert Einstein College of Medicine/Montefiore Medical CenterNew YorkUSA
  4. 4.Department of Epidemiology and Population HealthAlbert Einstein College of Medicine/Montefiore Medical CenterNew YorkUSA
  5. 5.Department of Biochemistry, Escola Paulista de MedicinaFederal University of Sao PauloSao PauloBrazil
  6. 6.Department of Molecular PharmacologyAlbert Einstein College of Medicine/Montefiore Medical CenterNew YorkUSA
  7. 7.Department of NeuroscienceAlbert Einstein College of Medicine/Montefiore Medical CenterNew YorkUSA
  8. 8.Department of Physiology and BiophysicsAlbert Einstein College of Medicine/Montefiore Medical CenterNew YorkUSA

Personalised recommendations